Hinge Health, Inc. (HNGE): “I Wanted To Find Out About Them,” Says Jim Cramer

We recently published 11 Stocks Jim Cramer Discussed As He Said Apple’s CEO Is A “Pawn”. Hinge Health, Inc. (NYSE:HNGE) is one of the stocks Jim Cramer recently discussed.

Hinge Health, Inc. (NYSE:HNGE) is a healthcare technology company that allows customers to utilize physical therapy through its software application. The shares have gained 48% year-to-date, after experiencing a 26% surge in August. Hinge Health, Inc. (NYSE:HNGE)’s shares rose after the firm reported its first earnings results after being listed for trading. The results saw the firm’s $139 million in revenue beat analyst estimates of $125 million. Since Hinge Health, Inc. (NYSE:HNGE) is yet to report a profit, analysts judged its operating performance through the cash flow. On this front, the firm’s $32 million in free cash flow also beat estimates of $20 million. Cramer shared that he had invited Hinge Health, Inc. (NYSE:HNGE) on Mad Money later in the day:

“And then Hinge Health, I don’t know them, I wanted to find out about them because people are excited about them.”

A stethoscope. Photo by Pixabay

The CNBC TV host previously discussed Hinge Health, Inc. (NYSE:HNGE) in July. Here is what he said:

“… After the quiet period ended mid-June, and Hinge received universally positive coverage from the analysts, the stock then took off again, climbing as high as $52 and change on the last day of June before pulling back to the mid-40s as of today. So I like that nice pullback from the top…

“… So the story sounds pretty good, right? Numbers are great, and now the only thing left to determine is how much should we pay for the stock. The 13 analysts that have stuck Buy ratings on Hinge have assigned price targets ranging from $41 to $52… So on an absolute basis, the stock seems a little pricey, trading 87 times this year’s numbers, 60 times next year’s numbers.

“However, I don’t think that’s a crazy multiple to pay for a stock in this stage of its development now, when it’s got such rapid growth. With Hinge’s earnings per share expected to grow by 45% next year, the stock has a price to earnings to growth ratio of 1.33 based on these numbers, which is actually far from expensive. In fact, using 2026 numbers, the S&P 500 currently has a 1.5 price to earnings to growth ratio. You could argue that, at least on this metric, Hinge is trading at a discount to the market.

“Bottom line: I think Hinge Health looks like another good option for investors like MNTN, Mountain. But unlike the high-flying CoreWeave or the Circle Internet, you know what? You get my blessing right now, right here to buy tomorrow morning. Yeah, I feel that good about it. As we peruse these mid-sized IPOs from the past several weeks, we’re finding some real nice up-and-coming companies with stocks that haven’t run too much, and I think some of them, like Hinge and Mountain, represent really good options for growth-oriented investors like you.”

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.